CliffBio
small molecule

OXYCONTIN

OXYCODONE HYDROCHLORIDE

Loss of exclusivityMarch 2030latest FDA-listed patent expiry
CompanyKNOA →See this company's full patent-cliff portfolio

Drug detail

Brand nameOXYCONTIN
Active ingredientOXYCODONE HYDROCHLORIDE
Strength15MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalApril 2010
Marketing statusRX

Listed patents

PatentExpiresType
8894987March 2030product
8808741August 2027use U-1556
9492391August 2027use U-1556
11304909August 2027use U-1556
9775808August 2027product
11964056August 2027product
9763933August 2027product
9770416August 2027product
12280152August 2027product
12246094August 2027product
11304908August 2027product
9492392August 2027product
9492389August 2027product
9492393August 2027use U-1556
8894988August 2027product

More from KNOA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.